Source: Business Wire

Press Release: Amplyx Pharmaceuticals : Global Candidiasis Pipeline Review, H2 2016 - Analysis, Technologies & Forecasts - Key Vendors: Amplyx Pharma, Bakker Medical, Biosergen - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Candidiasis - Pipeline Review, H2 2016" report to their offering. The report provides comprehensive information on the therapeutics under development for Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and devel

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Ciara Kennedy's photo - President & CEO of Amplyx

President & CEO

Ciara Kennedy

CEO Approval Rating

89/100

Amplyx is a biotechnology company that researches, develops and commercializes novel therapeutics for the treatment of fungal infections. Read more